FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Paroxetine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 28 USDMF, 15 CEP/COS, 9 JDMF, 11 EU WC, 13 KDMF, 14 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

490 FDF Dossiers, 96 FDA Orange Book, 268 Europe, 57 Canada, 16 Australia, 23 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 28 BASF, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 1 Gloria Interchem, 9 Ideal Cures, 3 Ingredion Pharma Solutions, 1 JJ Chemicals, 23 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

60 Coating Systems & Additives, 59 Fillers, Diluents & Binders, 33 Controlled & Modified Release, 31 Direct Compression, 29 Solubilizers, 28 Granulation, 25 Film Formers & Plasticizers, 23 Thickeners and Stabilizers, 21 Disintegrants & Superdisintegrants, 20 Parenteral, 20 Topical, 19 Taste Masking, 17 Lubricants & Glidants, 14 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 48 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 69 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

14 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

55 Health Canada Patents

55 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 1 USP, 4 JP, 15 Others

ANALYTICAL

4 BioAnalytical Methods, 1 Analytical Methods

$ Xls

Filters

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

TABLET;ORAL - EQ 30MG BASE

TABLET;ORAL - EQ 40MG BASE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Paroxetine Hydrochloride

Paroxetine Hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

72 API Suppliers

28 USDMF

15 CEP/COS

9 JDMF

11 EU WC

13 KDMF

14 NDC API

24 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

490 FDF Dossiers

96 FDA Orange Book

268 Europe

57 Canada

16 Australia

23 South Africa

30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 30MG BASE

TABLET;ORAL - EQ 40MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Evonik

1 Rochem International Inc

6 SPI Pharma

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

2 Kirsch Pharma

1 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

28 BASF

1 Clariant

14 Corel Pharma Chem

6 DFE Pharma

1 Doshion Polyscience

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

1 Gloria Interchem

9 Ideal Cures

3 Ingredion Pharma Solutions

1 JJ Chemicals

23 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

26 Roquette

14 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd